1
|
Ribeiro JR, Roca TP, Cartonilho GDS, Passos-Silva AM, Moreira HM, Teixeira KS, da Silva ALF, Lugtenburg CAB, dos Santos AO, Villalobos Salcedo JM, do Nascimento VA, de Souza VC, Roque RA, Krieger MA, Naveca FG, Rampazzo RDCP, Vieira DS. DENV-2 Outbreak Associated With Cosmopolitan Genotype Emergence in Western Brazilian Amazon. Bioinform Biol Insights 2024; 18:11779322241251581. [PMID: 38737722 PMCID: PMC11088811 DOI: 10.1177/11779322241251581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Accepted: 04/14/2024] [Indexed: 05/14/2024] Open
Abstract
Background Dengue virus (DENV) causes an important disease and directly affects public health, being the arbovirus that presents the highest number of infections and deaths in the Western Brazilian Amazon. This virus is divided into 4 serotypes that have already circulated in the region. Methodology Molecular characterization of a cohort containing 841 samples collected from febrile patients between 2021 and 2023 was analyzed using a commercial kit to detect the main arboviruses circulating in Brazil: Zika, DENV-1, DENV-2, DENV-3, DENV-4 and, Chikungunya. Subsequently, Sanger sequencing was performed for positive samples. Results The cohort detected 162 positive samples, 12 for DENV-1 and 150 identified as DENV-2, indicating co-circulation of serotypes. The samples were subjected to sequencing and the analysis of the sequences that obtained good quality revealed that 5 samples belonged to the V genotype of DENV-1 and 46 were characterized as DENV-2 Cosmopolitan genotype-lineage 5. Conclusion The results allowed us to identify for the first time the Cosmopolitan genotype in Rondônia, Brazilian Western Amazon, and its fast spread dispersion.
Collapse
Affiliation(s)
- Jessiane Rodrigues Ribeiro
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondônia—Fiocruz Rondônia (FIOCRUZ/RO), Porto Velho, Brazil
- Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental—INCT-EpiAmO, Porto Velho, Brazil
| | - Tárcio Peixoto Roca
- Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental—INCT-EpiAmO, Porto Velho, Brazil
- Programa de Pós-Graduação em Medicina Tropical, Instituto Oswaldo Cruz/IOC, FIOCRUZ, Rio de Janeiro, Brazil
| | - Gleense dos Santos Cartonilho
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondônia—Fiocruz Rondônia (FIOCRUZ/RO), Porto Velho, Brazil
- Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental—INCT-EpiAmO, Porto Velho, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondônia—UNIR/FIOCRUZ/RO, Porto Velho, Brazil
| | - Ana Maísa Passos-Silva
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondônia—Fiocruz Rondônia (FIOCRUZ/RO), Porto Velho, Brazil
- Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental—INCT-EpiAmO, Porto Velho, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondônia—UNIR/FIOCRUZ/RO, Porto Velho, Brazil
| | - Hillquias Monteiro Moreira
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondônia—Fiocruz Rondônia (FIOCRUZ/RO), Porto Velho, Brazil
- Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental—INCT-EpiAmO, Porto Velho, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondônia—UNIR/FIOCRUZ/RO, Porto Velho, Brazil
| | - Karolaine Santos Teixeira
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondônia—Fiocruz Rondônia (FIOCRUZ/RO), Porto Velho, Brazil
- Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental—INCT-EpiAmO, Porto Velho, Brazil
| | - André Luiz Ferreira da Silva
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondônia—Fiocruz Rondônia (FIOCRUZ/RO), Porto Velho, Brazil
- Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental—INCT-EpiAmO, Porto Velho, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondônia—UNIR/FIOCRUZ/RO, Porto Velho, Brazil
| | | | | | | | | | - Victor Costa de Souza
- Instituto Leônidas & Maria Deane—Fundação Oswaldo Cruz do Amazonas, ILMD, Manaus, Brazil
| | | | | | - Felipe Gomes Naveca
- Instituto Leônidas & Maria Deane—Fundação Oswaldo Cruz do Amazonas, ILMD, Manaus, Brazil
| | | | - Deusilene Souza Vieira
- Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondônia—Fiocruz Rondônia (FIOCRUZ/RO), Porto Velho, Brazil
- Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental—INCT-EpiAmO, Porto Velho, Brazil
- Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondônia—UNIR/FIOCRUZ/RO, Porto Velho, Brazil
| |
Collapse
|
2
|
Braun M, Andersen LK, Norton SA, Coates SJ. Dengue: updates for dermatologists on the world's fastest-growing vector-borne disease. Int J Dermatol 2023; 62:1110-1120. [PMID: 37306140 DOI: 10.1111/ijd.16739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 04/30/2023] [Accepted: 05/23/2023] [Indexed: 06/13/2023]
Abstract
Dengue is the world's fastest-growing vector borne disease and has significant epidemic potential in suitable climates. Recent disease models incorporating climate change scenarios predict geographic expansion across the globe, including parts of the United States and Europe. It will be increasingly important in the next decade for dermatologists to become familiar with dengue, as it commonly manifests with rashes, which can be used to aid diagnosis. In this review, we discuss dengue for general dermatologists, specifically focusing on its cutaneous manifestations, epidemiology, diagnosis, treatment, and prevention. As dengue continues to spread in both endemic and new locations, dermatologists may have a larger role in the timely diagnosis and management of this disease.
Collapse
Affiliation(s)
- Mitchell Braun
- Department of Dermatology, The University of California San Francisco, San Francisco, CA, USA
| | - Louise K Andersen
- Department of Dermatology, Aleris-Hamlet Private Hospital, Esbjerg, Denmark
| | - Scott A Norton
- Departments of Dermatology and Preventive Medicine & Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
| | - Sarah J Coates
- Department of Dermatology, The University of California San Francisco, San Francisco, CA, USA
| |
Collapse
|
3
|
Thergarajan G, Sekaran SD. Diagnostic approaches for dengue infection. Expert Rev Mol Diagn 2023; 23:643-651. [PMID: 37417532 DOI: 10.1080/14737159.2023.2234815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Accepted: 07/06/2023] [Indexed: 07/08/2023]
Abstract
INTRODUCTION Every year, a significant rise in dengue incidence observed is responsible for 10% of fever episodes in children and adolescents in endemic countries. Considering that the symptoms of dengue are similar to those of many other viruses, early diagnosis of the disease has long been difficult, and lack of sensitive diagnostic tools may be another factor contributing to a rise in dengue incidence. AREAS COVERED This review will highlight dengue diagnostics strategies and discuss other possible targets for dengue diagnosis. Understanding the dynamics of the immune response and how it affects viral infection has enabled informed diagnosis. As more technologies emerge, precise assays that include some clinical markers need to be included. EXPERT OPINION Future diagnostic strategies will require the use both viral and clinical markers in a serial manner with the use of artificial intelligence technology to determine from the first point of illness to better determine severity status and management. A definitive endpoint is not in the horizon as the disease as well as the virus is constantly evolving and hence many developed assays need to be constantly changing some of their reagents periodically as newer genotypes and probably too serotypes emerge.
Collapse
|
4
|
Lim PY, Ramapraba A, Loy T, Rouers A, Thein TL, Leo YS, Burton DR, Fink K, Wang CI. A nonstructural protein 1 capture enzyme-linked immunosorbent assay specific for dengue viruses. PLoS One 2023; 18:e0285878. [PMID: 37200264 PMCID: PMC10194908 DOI: 10.1371/journal.pone.0285878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2022] [Accepted: 05/03/2023] [Indexed: 05/20/2023] Open
Abstract
Dengue non-structural protein (NS1) is an important diagnostic marker during the acute phase of infection. Because NS1 is partially conserved across the flaviviruses, a highly specific DENV NS-1 diagnostic test is needed to differentiate dengue infection from Zika virus (ZIKV) infection. In this study, we characterized three newly isolated antibodies against NS1 (A2, D6 and D8) from a dengue-infected patient and a previously published human anti-NS1 antibody (Den3). All four antibodies recognized multimeric forms of NS1 from different serotypes. A2 bound to NS1 from DENV-1, -2, and -3, D6 bound to NS1 from DENV-1, -2, and -4, and D8 and Den3 interacted with NS1 from all four dengue serotypes. Using a competition ELISA, we found that A2 and D6 bound to overlapping epitopes on NS1 whereas D8 recognized an epitope distinct from A2 and D6. In addition, we developed a capture ELISA that specifically detected NS1 from dengue viruses, but not ZIKV, using Den3 as the capture antibody and D8 as the detecting antibody. This assay detected NS1 from all the tested dengue virus strains and dengue-infected patients. In conclusion, we established a dengue-specific capture ELISA using human antibodies against NS1. This assay has the potential to be developed as a point-of-care diagnostic tool.
Collapse
Affiliation(s)
- Pei-Yin Lim
- Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore
| | - Appanna Ramapraba
- Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore
| | - Thomas Loy
- Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore
| | - Angeline Rouers
- Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore
| | - Tun-Linn Thein
- National Centre for Infectious Diseases, Singapore, Singapore
| | - Yee-Sin Leo
- National Centre for Infectious Diseases, Singapore, Singapore
| | - Dennis R. Burton
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, United States of America
| | - Katja Fink
- Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore
| | - Cheng-I Wang
- Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore
| |
Collapse
|
5
|
Le TN, Hsiao WWW, Cheng YY, Lee CC, Huynh TT, Pham DM, Chen M, Jen MW, Chang HC, Chiang WH. Spin-Enhanced Lateral Flow Immunoassay for High-Sensitivity Detection of Nonstructural Protein NS1 Serotypes of the Dengue Virus. Anal Chem 2022; 94:17819-17826. [PMID: 36512513 DOI: 10.1021/acs.analchem.2c03521] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Dengue fever is a global mosquito-borne viral infectious disease that has, in recent years, rapidly spread to almost all regions of the world. Lack of vaccination and directed treatment makes detection at the infection's early stages extremely important for disease prevention and clinical care. In this paper, we developed a rapid and highly sensitive dengue detection tool using a novel platform of diagnosis, called spin-enhanced lateral flow immunoassay (SELFIA) with a fluorescent nanodiamond (FND) as a reporter. Taking advantage of the unique magneto-optical properties of negatively charged nitrogen-vacancy centers in the FND, the SELFIA platform utilizes alternating electromagnetic fields to modulate signals from FND's fluorescence to provide sensitive and specific results. With sandwich SELFIA, we could efficiently detect all four dengue non-structural protein (NS1) serotypes (DV1, DV2, DV3, and DV4). The lowest detection concentration of the dengue NS1 antigens varied from 0.1 to 1.3 ng/mL, which is among the lowest limits of detection to date. The FND-based SELFIA technique is up to 500 and 5000 times more sensitive than carbon black and conventional gold nanoparticles, respectively. By using different anti-NS1 antibodies, we could differentiate the NS1 antigen serotypes contained in the tested samples via three simultaneous assays. Proposed SELFIA allows for both qualitative and quantitative differentiation between different NS1 protein serotypes, which will assist in the development of a highly sensitive and specific detection platform for dengue screening that has the potential to detect the disease at its early stages, especially in high-risk and limited-resource areas.
Collapse
Affiliation(s)
- Trong-Nghia Le
- Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106, Taiwan.,Institute of Atomic and Molecular Sciences, Academia Sinica, Taipei 10617, Taiwan
| | - Wesley Wei-Wen Hsiao
- Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106, Taiwan
| | - Yu-Yuan Cheng
- Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106, Taiwan
| | - Cheng-Chung Lee
- Institute of Biological Chemistry, Academia Sinica, Taipei 10617, Taiwan.,The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 10617, Taiwan
| | - Tan-Thanh Huynh
- School of Applied Chemistry, Tra Vinh University, Tra Vinh 87110, Viet Nam
| | - Dinh Minh Pham
- Institute of Biotechnology, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet, Cau Giay, Hanoi 10000, Vietnam
| | - Marvin Chen
- Institute of Atomic and Molecular Sciences, Academia Sinica, Taipei 10617, Taiwan.,College of Letter and Science, the University of California, Berkeley, California 94720, U.S.A
| | - Ming-Wei Jen
- Institute of Atomic and Molecular Sciences, Academia Sinica, Taipei 10617, Taiwan.,College of Education and Human Ecology, the Ohio State University, Columbus, Ohio 43210, U.S.A
| | - Huan-Cheng Chang
- Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106, Taiwan.,Institute of Atomic and Molecular Sciences, Academia Sinica, Taipei 10617, Taiwan
| | - Wei-Hung Chiang
- Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106, Taiwan
| |
Collapse
|
6
|
Differential critical residues on the overlapped region of the non-structural protein-1 recognized by flavivirus and dengue virus cross-reactive monoclonal antibodies. Sci Rep 2022; 12:21548. [PMID: 36513793 PMCID: PMC9747715 DOI: 10.1038/s41598-022-26097-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Accepted: 12/09/2022] [Indexed: 12/14/2022] Open
Abstract
The non-structural protein-1 (NS1) of dengue virus (DENV) contributes to several functions related to dengue disease pathogenesis as well as diagnostic applications. Antibodies against DENV NS1 can cross-react with other co-circulating flaviviruses, which may lead to incorrect diagnosis. Herein, five anti-DENV NS1 monoclonal antibodies (mAbs) were investigated. Four of them (1F11, 2E3, 1B2, and 4D2) cross-react with NS1 of all four DENV serotypes (pan-DENV mAbs), whereas the other (2E11) also reacts with NS1 of other flaviviruses (flavi-cross-reactive mAb). The binding epitopes recognized by these mAbs were found to overlap a region located on the disordered loop of the NS1 wing domain (amino acid residues 104 to 123). Fine epitope mapping employing phage display technology and alanine-substituted DENV2 NS1 mutants indicates the critical binding residues W115, K116, and K120 for the 2E11 mAb, which are conserved among flaviviruses. In contrast, the critical binding residues of four pan-DENV mAbs include both flavi-conserved residues (W115 to G119) and DENV-conserved flanking residues (K112, Y113, S114 and A121, K122). Our results highlight DENV-conserved residues in cross-reactive epitopes that distinguish pan-DENV antibodies from the flavi-cross-reactive antibody. These antibodies can be potentially applied to differential diagnosis of DENV from other flavivirus infections.
Collapse
|
7
|
Poltep K, Phadungsombat J, Kosoltanapiwat N, Hanboonkunupakarn B, Wiriyarat W, Suwanpakdee S, Prompiram P, Nakayama EE, Suzuki K, Iwamoto H, Shioda T, Leaungwutiwong P. Performance of the onstructural 1 Antigen Rapid Test for detecting all four DENV serotypes in clinical specimens from Bangkok, Thailand. Virol J 2022; 19:169. [PMID: 36303183 PMCID: PMC9610331 DOI: 10.1186/s12985-022-01904-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2022] [Revised: 10/03/2022] [Accepted: 10/13/2022] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Dengue is an arboviral disease that has a large effect on public health in subtropical and tropical countries. Rapid and accurate detection of dengue infection is necessary for diagnosis and disease management. We previously developed highly sensitive immunochromatographic devices, the TKK 1st and TKK 2nd kits, based on dengue virus (DENV) nonstructural protein 1 detection. However, these TKK kits were evaluated mainly using DENV type 2 clinical specimens collected in Bangladesh, and further validation using clinical specimens of other serotypes was needed. METHODS In the present study, one of the TKK kits, TKK 2nd, was evaluated using 10 DENV-1, 10 DENV-2, 4 DENV-3, 16 DENV-4, and 10 zika virus-infected clinical specimens collected in Bangkok, Thailand. RESULTS The TKK 2nd kit successfully detected all four DENV serotypes in patient serum specimens and did not show any cross-reactivities against zika virus serum specimens. The IgM and/or IgG anti-DENV antibodies were detected in seven serum specimens, but did not seem to affect the results of antigen detection in the TKK 2nd kit. CONCLUSION The results showed that the TKK 2nd kit successfully detected all four DENV serotypes in clinical specimens and confirmed the potential of the kit for dengue diagnosis in endemic countries.
Collapse
Affiliation(s)
- Kanaporn Poltep
- Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi road, Ratchathewi, 10400, Bangkok, Thailand
- Mahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi road, Ratchathewi, 10400, Bangkok, Thailand
- The Monitoring and Surveillance Center for Zoonotic Diseases in Wildlife and Exotic Animals (MoZWE), Faculty of Veterinary Science, Mahidol University, 999 Phutthamonthon Sai 4 Road, 73170, Phutthamonthon, Nakhonpathom, Thailand
| | - Juthamas Phadungsombat
- Mahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi road, Ratchathewi, 10400, Bangkok, Thailand
- Center for Infectious Disease Education and Research (CiDER), Department of Viral Infections, Research Institute for Microbial Diseases (RIMD), Osaka University, 3-1, Yamada-oka, 565-0871, Suita, Osaka, Japan
| | - Nathamon Kosoltanapiwat
- Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi road, Ratchathewi, 10400, Bangkok, Thailand
| | - Borimas Hanboonkunupakarn
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi road, Ratchathewi, 10400, Bangkok, Thailand
| | - Witthawat Wiriyarat
- The Monitoring and Surveillance Center for Zoonotic Diseases in Wildlife and Exotic Animals (MoZWE), Faculty of Veterinary Science, Mahidol University, 999 Phutthamonthon Sai 4 Road, 73170, Phutthamonthon, Nakhonpathom, Thailand
| | - Sarin Suwanpakdee
- The Monitoring and Surveillance Center for Zoonotic Diseases in Wildlife and Exotic Animals (MoZWE), Faculty of Veterinary Science, Mahidol University, 999 Phutthamonthon Sai 4 Road, 73170, Phutthamonthon, Nakhonpathom, Thailand
| | - Phirom Prompiram
- The Monitoring and Surveillance Center for Zoonotic Diseases in Wildlife and Exotic Animals (MoZWE), Faculty of Veterinary Science, Mahidol University, 999 Phutthamonthon Sai 4 Road, 73170, Phutthamonthon, Nakhonpathom, Thailand
| | - Emi E Nakayama
- Mahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi road, Ratchathewi, 10400, Bangkok, Thailand
- Center for Infectious Disease Education and Research (CiDER), Department of Viral Infections, Research Institute for Microbial Diseases (RIMD), Osaka University, 3-1, Yamada-oka, 565-0871, Suita, Osaka, Japan
| | - Keita Suzuki
- POCT Business Unit, TANAKA Kikinzoku Kogyo K.K, 2-73, 254-0076, Shinmachi, Hiratsuka, Kanagawa, Japan
| | - Hisahiko Iwamoto
- POCT Business Unit, TANAKA Kikinzoku Kogyo K.K, 2-73, 254-0076, Shinmachi, Hiratsuka, Kanagawa, Japan
| | - Tatsuo Shioda
- Mahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi road, Ratchathewi, 10400, Bangkok, Thailand.
- Center for Infectious Disease Education and Research (CiDER), Department of Viral Infections, Research Institute for Microbial Diseases (RIMD), Osaka University, 3-1, Yamada-oka, 565-0871, Suita, Osaka, Japan.
| | - Pornsawan Leaungwutiwong
- Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi road, Ratchathewi, 10400, Bangkok, Thailand.
| |
Collapse
|
8
|
Needs SH, Sirivisoot S, Jegouic S, Prommool T, Luangaram P, Srisawat C, Sriraksa K, Limpitikul W, Mairiang D, Malasit P, Avirutnan P, Puttikhunt C, Edwards AD. Smartphone multiplex microcapillary diagnostics using Cygnus: Development and evaluation of rapid serotype-specific NS1 detection with dengue patient samples. PLoS Negl Trop Dis 2022; 16:e0010266. [PMID: 35389998 PMCID: PMC8989202 DOI: 10.1371/journal.pntd.0010266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Accepted: 02/18/2022] [Indexed: 11/18/2022] Open
Abstract
Laboratory diagnosis of dengue virus (DENV) infection including DENV serotyping requires skilled labor and well-equipped settings. DENV NS1 lateral flow rapid test (LFT) provides simplicity but lacks ability to identify serotype. A simple, economical, point-of-care device for serotyping is still needed. We present a gravity driven, smartphone compatible, microfluidic device using microcapillary film (MCF) to perform multiplex serotype-specific immunoassay detection of dengue virus NS1. A novel device–termed Cygnus–with a stackable design allows analysis of 1 to 12 samples in parallel in 40 minutes. A sandwich enzyme immunoassay was developed to specifically detect NS1 of all four DENV serotypes in one 60-μl plasma sample. This test aims to bridge the gap between rapid LFT and laboratory microplate ELISAs in terms of sensitivity, usability, accessibility and speed. The Cygnus NS1 assay was evaluated with retrospective undiluted plasma samples from 205 DENV infected patients alongside 50 febrile illness negative controls. Against the gold standard RT-PCR, clinical sensitivity for Cygnus was 82% in overall (with 78, 78, 80 and 76% for DENV1-4, respectively), comparable to an in-house serotyping NS1 microplate ELISA (82% vs 83%) but superior to commercial NS1-LFT (82% vs 74%). Specificity of the Cygnus device was 86%, lower than that of NS1-microplate ELISA and NS1-LFT (100% and 98%, respectively). For Cygnus positive samples, identification of DENV serotypes DENV2-4 matched those by RT-PCR by 100%, but for DENV1 capillaries false positives were seen, suggesting an improved DENV1 capture antibody is needed to increase specificity. Overall performance of Cygnus showed substantial agreement to NS1-microplate ELISA (κ = 0.68, 95%CI 0.58–0.77) and NS1-LFT (κ = 0.71, 95%CI 0.63–0.80). Although further refinement for DENV-1 NS1 detection is needed, the advantages of multiplexing and rapid processing time, this Cygnus device could deliver point-of-care NS1 antigen testing including serotyping for timely DENV diagnosis for epidemic surveillance and outbreak prediction. Diagnosis of the important mosquito-transmitted dengue virus (DENV) requires laboratory assays to detect viral genome (RT-PCR), viral NS1 protein (immunoassay) or DENV specific antibodies. Current point-of-care NS1 tests cannot distinguish serotype, so laboratory tests are still essential to determine which of 4 DENV serotypes is present. Here we present a rapid serotype-specific NS1 test in a portable microfluidic format. Ten parallel 0.2 mm tubes inside a flat plastic ribbon perform multiplex NS1 immunoassays. A simple cassette delivers sample and reagents sequentially through the microcapillaries by gravity. By stacking cassettes, 12 tests could be performed in under 40 minutes, with results recorded by smartphone. When evaluated with 205 patients plus 50 control samples, and results compared to conventional RT-PCR, the sensitivity for DENV1 to 4 was 78%, 78%, 80%, and 76%, respectively, with specificity of 100% for DENV2-4. DENV1 showed some false positives due to cross-reactivity of the capture antibody. Serotyping performance with MCF-Cygnus devices showed substantial agreement to the serotyping-NS1 microplate ELISA. Therefore, these simple and portable microcapillary immunoassay devices could support dengue NS1 serotyping with potential benefits for near-patient diagnosis, real-time epidemic surveillance and outbreak mapping.
Collapse
Affiliation(s)
- Sarah Helen Needs
- Reading School of Pharmacy, University of Reading, Whiteknights, Reading, United Kingdom
| | - Sirintra Sirivisoot
- Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Sophie Jegouic
- Reading School of Pharmacy, University of Reading, Whiteknights, Reading, United Kingdom
| | - Tanapan Prommool
- Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand
| | - Prasit Luangaram
- Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand
| | - Chatchawan Srisawat
- Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Kanokwan Sriraksa
- Pediatric Department, Khon Kaen Hospital, Ministry of Health, Khon Kaen, Thailand
| | - Wannee Limpitikul
- Pediatric Department, Songkhla Hospital, Ministry of Health, Songkhla, Thailand
| | - Dumrong Mairiang
- Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
- Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand
- Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Prida Malasit
- Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
- Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand
- Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Panisadee Avirutnan
- Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
- Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand
- Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
- * E-mail: (PA); (CH); (ADE)
| | - Chunya Puttikhunt
- Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
- Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand
- Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
- * E-mail: (PA); (CH); (ADE)
| | - Alexander Daniel Edwards
- Reading School of Pharmacy, University of Reading, Whiteknights, Reading, United Kingdom
- Capillary Film Technology Ltd, Billingshurst, West Sussex, United Kingdom
- * E-mail: (PA); (CH); (ADE)
| |
Collapse
|
9
|
Development of a Dengue Virus Serotype-Specific Non-Structural Protein 1 Capture Immunochromatography Method. SENSORS 2021; 21:s21237809. [PMID: 34883813 PMCID: PMC8659457 DOI: 10.3390/s21237809] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Revised: 11/21/2021] [Accepted: 11/22/2021] [Indexed: 11/17/2022]
Abstract
Four serotypes of dengue virus (DENV), type 1 to 4 (DENV-1 to DENV-4), exhibit approximately 25–40% of the difference in the encoded amino acid residues of viral proteins. Reverse transcription of RNA extracted from specimens followed by PCR amplification is the current standard method of DENV serotype determination. However, since this method is time-consuming, rapid detection systems are desirable. We established several mouse monoclonal antibodies directed against DENV non-structural protein 1 and integrated them into rapid DENV detection systems. We successfully developed serotype-specific immunochromatography systems for all four DENV serotypes. Each system can detect 104 copies/mL in 15 min using laboratory and clinical isolates of DENV. No cross-reaction between DENV serotypes was observed in these DENV isolates. We also confirmed that there was no cross-reaction with chikungunya, Japanese encephalitis, Sindbis, and Zika viruses. Evaluation of these systems using serum from DENV-infected individuals indicated a serotype specificity of almost 100%. These assay systems could accelerate both DENV infection diagnosis and epidemiologic studies in DENV-endemic areas.
Collapse
|